Molecular docking study of fda-approved drugs to inhibit the bacterial ribosome

Ateş, Beril
Yüce, Merve
Levitaş, Ozge Kurkcuoglu
Sungur, Fethiye Aylin
Ribosomes are large macromolecular complexes responsible for cellular protein synthesis. It consists of two subunits; called 30S small and 50S large subunits in bacteria, involving antibiotic binding regions. This mac- romolecular machine is one of the significant targets of conventional antibiotics because protein synthesis can be stopped by targeting functional sites in the ribosome. For instance, several antibiotics target the decoding center responsible for deciphering the genetic code, as well as mRNA corridor on the 30S subunit. However, antibiotic resistance is a growing threat, and new molecules are urgently needed to be developed. This compu- tational work aims to find new potential inhibitors of E. coli ribosome from FDA-approved drug library. First, 30S subunit used as the target is obtained from the crystal structure of E. coli 70S ribosome (PDB ID: 4v64). 30S small subunit is prepared in Protein Preparation Wizard, ligands are prepared in LigPrep module of Maes- tro. Standard (SP) and extra precision (XP) docking scoring protocols are performed in Glide and binding free energies of hit compounds are calculated using Prime MM/GBSA module. SP and XP docking scores of the ligand bound to the crystal structure are determined and then used as reference values to select the hit com- pounds. According to the results, several antibiotics such as framycetin and amikacin that already target 30S have the highest binding free energy scores, verifying our approach. Antibiotics, hormone agonists, antidiuretic hormones, and drugs used for the treatment of tumors and obesity are determined as promising against bacterial ribosomes. Generally, hit compounds make hydrogen bonds with nucleotides C1403, C1404, G1491, A1492, A1493, G1494, U1495 and G1497 next to the decoding center. In the light of these results, proposed hit mole- cules and their interactions can be also useful for pharmacophore design and guide further experimental stud- ies.


Molecular cloning, characterization, and expression analysis of a gene encoding a Ran binding protein (RanBP) in Cucumis melo L.
Baloglu, Mehmet Cengiz; Zakharov, Florence Negre; Öktem, Hüseyin Avni; Yücel, Ayşe Meral (2011-01-01)
Ran binding proteins (RanBPs) are highly conserved members of the GTP-binding protein family that are involved in nuclear protein export between the nucleus and the cytoplasm. In this study, a CmRanBP gene from a melon was isolated (Cucumis melo L.) using the RACE (rapid amplification of cDNA ends) method. The 778 basepair long melon, with a RanBP cDNA encoding consisting of 197 amino acids (22.2 kDa protein), was characterized (GenBank accession no: EU853459). The predicted amino acid sequence of CmRanBP w...
Structural characterization of recombinant bovine Go alpha by spectroscopy and homology modeling
MEGA TİBER, PINAR; Orun, Oya; Nacar, Cevdet; Sezerman, Ugur Osman; Severcan, Feride; Severcan, Mete; Matagne, Andre; KAN, BEKİ (2011-01-01)
Go, a member of heterotrimeric guanine nucleotide-binding proteins, is the most abundant form of G protein in the central and peripheral nervous systems. Go alpha has a significant role in neuronal development and function but its signal transduction mechanism remains to be clarified.
Evaluation of functional changes in akr1b1 and akr1b10 overexpressing colorectal cancer cell lines
Güderer, İsmail; Banerjee, Sreeparna; Department of Biology (2021-2-15)
Aldo-keto reductases (AKRs) are nicotinamide adenine dinucleotide phosphate (NADPH)-dependent enzymes with diverse cellular metabolism functions. AKR1B1 and AKR1B10 are two of the most studied enzymes in the AKR family. AKR1B1 reduces excess glucose into sorbitol using reducing electrons from NADPH, and the hyperactivation of the AKR1B1 pathways is associated with oxidative stress and cell death. AKR1B10 is a poor reductant of glucose but is a vital enzyme that can metabolize retinol and many other drugs an...
Investigation of the therapeutic effect of sodium butyrate in Caco-2 colon cancer cell line by using ATR-FTIR spectroscopy
Çelik, Buket; Bek, Alpan; Özek, Nihal Şimşek; Department of Micro and Nanotechnology (2018)
Sodium butyrate (NaBt), as one of the HDACi, has been demonstrated that it induces apoptosis, cell cycle arrest, the inhibition of angiogenesis, metastasis and gene expression changes. To date, there are several studies perfomed to investigate its therapeutic effect; however, theexact mechanism at molecular level is not clear yet. Therefore, the current thesis was aimed to clarify the action/theurapeutic potential mechanisms of sodium butyrate in Caco2 colon cancer cell line at molecular level using ATR-FTI...
Chemoselective Immobilization of Proteins by Microcontact Printing and Bio-orthogonal Click Reactions
Tolstyka, Zachary P.; Richardson, Wade; Bat, Erhan; Stevens, Caitlin J.; Parra, Dayanara P.; Dozier, Jonathan K.; Distefano, Mark D.; Dunn, Bruce; Maynard, Heather D. (Wiley, 2013-12-16)
Herein, a combination of microcontact printing of functionalized alkanethiols and site-specific modification of proteins is utilized to chemoselectively immobilize proteins onto gold surfaces, either by oxime- or copper-catalyzed alkyne-azide click chemistry. Two molecules capable of click reactions were synthesized, an aminooxy-functionalized alkanethiol and an azide-functionalized alkanethiol, and self-assembled monolayer (SAM) formation on gold was confirmed by IR spectroscopy. The alkanethiols were then...
Citation Formats
B. Ateş, M. Yüce, O. K. Levitaş, and F. A. Sungur, “Molecular docking study of fda-approved drugs to inhibit the bacterial ribosome,” Erdemli, Mersin, TÜRKİYE, 2022, p. 3049, Accessed: 00, 2023. [Online]. Available: